Abstract
A method of diagnosing and/or prognosing an abnormality, such as a proliferative disorder in a subject, includes performing an IR spectroscopic analysis of a wet biofluid sample, such as a blood sample (or component thereof) from the subject; to produce a spectroscopic signature characteristic of the biofluid/blood sample (or component thereof).
Original language | English |
---|---|
Patent number | WO2017221027A1 |
IPC | A61B5/00,G01N33/68 |
Priority date | 24/04/16 |
Filing date | 23/06/17 |
Publication status | Published - 28 Dec 2017 |
Keywords
- infrared spectroscopy
- analysis of bodily fluids
- cancer diagnosis
- IR spectroscopic analysis
- wet biofluid sample